Radiolabelling broadly neutralizing anti-HIV antibody 3BNC117 with a Copper-64 radio isotope
for infusion into people with HIV followed by MRI/PET scanning to detect HIV in vivo.
Phase:
Phase 1
Details
Lead Sponsor:
Bayside Health
Collaborators:
Austin Health Monash Health Monash University Rockefeller University The Peter Doherty Institute for Infection and Immunity